Literature DB >> 29195677

Do smoking and alcohol behaviours influence GI cancer survival?

Úna C McMenamin1, Stephen McCain2, Andrew T Kunzmann3.   

Abstract

Little is known about the role of alcohol and smoking in GI cancer survival compared to GI cancer development. We systematically reviewed the evidence for a role of smoking and alcohol in prognosis among GI cancer patients and inform whether smoking or alcohol cessation interventions or guidelines for GI cancer patients are likely to improve prognosis. A total of 84 relevant studies were identified. Continued smokers, particularly heavy smokers, had worse prognosis than never smokers in most GI cancers. However, more evidence is needed to establish the likely impact of smoking cessation interventions amongst GI cancer patients. Heavy alcohol drinkers had worse prognosis in oesophageal squamous cell carcinoma and hepatocellular carcinoma patients. Light alcohol consumption was not associated with worse prognosis from any GI cancer, though further studies are needed. UK guidelines for the general population recommending under 14 units (∼7 drinks) per week may be sufficient for GI cancer patients, until further evidence is available.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol; Cancer; Prognosis; Smoking; Survival

Mesh:

Year:  2017        PMID: 29195677     DOI: 10.1016/j.bpg.2017.09.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  Smoking and gastrointestinal cancer patients-is smoking cessation an attainable goal?

Authors:  James R Barrett; Linda Cherney-Stafford; Esra Alagoz; Megan E Piper; Jessica Cook; Stephanie Campbell-Flohr; Sharon M Weber; Emily R Winslow; Sean M Ronnkleiv-Kelly; Daniel E Abbott
Journal:  J Surg Oncol       Date:  2019-10-31       Impact factor: 3.454

2.  Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.

Authors:  ZhiYu Zhao; Wei Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

3.  Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time.

Authors:  Paul P Fahey; Andrew Page; Thomas Astell-Burt; Glenn Stone
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

4.  Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study.

Authors:  Jingwen Liu; Yongjian Chen; Xiangyu Zhan; Yunfang Yu; Herui Yao
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

5.  Augmenting cancer registry data with health survey data with no cases in common: the relationship between pre-diagnosis health behaviour and post-diagnosis survival in oesophageal cancer.

Authors:  Paul P Fahey; Andrew Page; Glenn Stone; Thomas Astell-Burt
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

Review 6.  Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Andrew McGuigan; Paul Kelly; Richard C Turkington; Claire Jones; Helen G Coleman; R Stephen McCain
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

7.  Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.

Authors:  R Stephen McCain; Damian T McManus; Stephen McQuaid; Jacqueline A James; Manuel Salto-Tellez; Nathan B Reid; Stephanie Craig; Chintapuza Chisambo; Victoria Bingham; Eamon McCarron; Eileen Parkes; Richard C Turkington; Helen G Coleman
Journal:  Cancer Causes Control       Date:  2019-11-30       Impact factor: 2.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.